secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001654954-24-008613
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision reports Q2 revenue of $94,840; approves 1-for-10 reverse stock split
--------------------------------------------------------------------------------

- Preliminary Q2 2024 revenue $94,840, including first LockeT sales ($40,500) and VIVO ($54,340).
- Six-month 2024 revenue $176,923; 15% sequential quarter-over-quarter growth.
- Board approved 1-for-10 reverse stock split effective July 15, 2024; shares reduce from 8.4M to ~839K.
- Series A Preferred conversion issued 814,228 common shares on July 1, 2024.
- New CCO Marie Claude Jaques hired in May; sales pipeline growing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424008613/0001654954-24-008613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424008613/rmed_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-008613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer